Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review.

Ya K, Tangamornsuksan W, Scholfield CN, Methaneethorn J, Lohitnavy M.

Asian J Psychiatr. 2019 Jun;43:73-82. doi: 10.1016/j.ajp.2019.05.016. Epub 2019 May 9.

PMID:
31100603
2.

Effects of unconventional recreational drug use in pregnancy.

Chomchai S, Phuditshinnapatra J, Mekavuthikul P, Chomchai C.

Semin Fetal Neonatal Med. 2019 Apr;24(2):142-148. doi: 10.1016/j.siny.2019.01.010. Epub 2019 Feb 4. Review.

PMID:
30744980
3.

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.

Lovrecic B, Lovrecic M, Gabrovec B, Carli M, Pacini M, Maremmani AGI, Maremmani I.

Int J Environ Res Public Health. 2019 Jan 9;16(2). pii: E177. doi: 10.3390/ijerph16020177. Review.

4.

Kratom Withdrawal: A Systematic Review with Case Series.

Stanciu CN, Gnanasegaram SA, Ahmed S, Penders T.

J Psychoactive Drugs. 2019 Jan-Mar;51(1):12-18. doi: 10.1080/02791072.2018.1562133. Epub 2019 Jan 5.

PMID:
30614408
5.

Neonatal Abstinence Syndrome Due to Maternal Kratom Use.

Eldridge WB, Foster C, Wyble L.

Pediatrics. 2018 Dec;142(6). pii: e20181839. doi: 10.1542/peds.2018-1839. Epub 2018 Nov 7. Review.

6.

Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Toce MS, Chai PR, Burns MM, Boyer EW.

J Med Toxicol. 2018 Dec;14(4):306-322. doi: 10.1007/s13181-018-0685-1. Epub 2018 Oct 30. Review.

7.

New opioid receptor modulators and agonists.

Kaye AD, Cornett EM, Patil SS, Gennuso SA, Colontonio MM, Latimer DR, Kaye AJ, Urman RD, Vadivelu N.

Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):125-136. doi: 10.1016/j.bpa.2018.06.009. Epub 2018 Jul 2. Review.

PMID:
30322454
8.

A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.

Bae K, Kwon NJ, Han E.

Forensic Sci Int. 2018 Nov;292:45-49. doi: 10.1016/j.forsciint.2018.09.008. Epub 2018 Sep 19. Review.

PMID:
30273913
9.

Kratom and General Anesthesia: A Case Report and Review of the Literature.

Vermaire DJ, Skaer D, Tippets W.

A A Pract. 2019 Feb 15;12(4):103-105. doi: 10.1213/XAA.0000000000000857. Review.

PMID:
30052532
10.

The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Henningfield JE, Fant RV, Wang DW.

Psychopharmacology (Berl). 2018 Feb;235(2):573-589. doi: 10.1007/s00213-017-4813-4. Epub 2017 Dec 23. Review.

11.

Pharmacologic and clinical assessment of kratom.

White CM.

Am J Health Syst Pharm. 2018 Mar 1;75(5):261-267. doi: 10.2146/ajhp161035. Epub 2017 Dec 18. Review.

PMID:
29255059
12.

Kratom use and mental health: A systematic review.

Swogger MT, Walsh Z.

Drug Alcohol Depend. 2018 Feb 1;183:134-140. doi: 10.1016/j.drugalcdep.2017.10.012. Epub 2017 Dec 7. Review.

PMID:
29248691
13.

New psychoactive substances of natural origin: A brief review.

Feng LY, Battulga A, Han E, Chung H, Li JH.

J Food Drug Anal. 2017 Jul;25(3):461-471. doi: 10.1016/j.jfda.2017.04.001. Epub 2017 Apr 18. Review.

14.

The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.

Kruegel AC, Grundmann O.

Neuropharmacology. 2018 May 15;134(Pt A):108-120. doi: 10.1016/j.neuropharm.2017.08.026. Epub 2017 Aug 19. Review.

PMID:
28830758
15.

Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.

Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman-Urrestarazu A.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2582. Epub 2017 May 24. Review.

PMID:
28544011
16.

A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom.

Brown PN, Lund JA, Murch SJ.

J Ethnopharmacol. 2017 Apr 18;202:302-325. doi: 10.1016/j.jep.2017.03.020. Epub 2017 Mar 19. Review.

PMID:
28330725
17.

Herbal Highs: Review on Psychoactive Effects and Neuropharmacology.

Graziano S, Orsolini L, Rotolo MC, Tittarelli R, Schifano F, Pichini S.

Curr Neuropharmacol. 2017;15(5):750-761. doi: 10.2174/1570159X14666161031144427. Review.

18.

Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature.

Singh D, Narayanan S, Vicknasingam B.

Brain Res Bull. 2016 Sep;126(Pt 1):41-46. doi: 10.1016/j.brainresbull.2016.05.004. Epub 2016 May 10. Review.

PMID:
27178014
19.

Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busard├▓ FP, Marinelli E.

Int J Mol Sci. 2016 Apr 16;17(4):580. doi: 10.3390/ijms17040580. Review.

20.

A Case Report of Kratom Addiction and Withdrawal.

Galbis-Reig D.

WMJ. 2016 Feb;115(1):49-52; quiz 53. Review.

Supplemental Content

Loading ...
Support Center